$DRI

Darden Restaurants (DRI) Set to Serve Up an 8% Move After Q1 Earnings, Say Options Traders

Darden Restaurants (DRI) is set to report Q1 earnings on September 24. The stock is up 17.2% YTD. Options traders expect an 8% move post-earnings. Wall Street forecasts EPS of $2.05 and revenue of $3.21B. DRI has a Moderate Buy consensus with a $233.35 avg. price target.

Original reporting
Published Sep 16, 2026, 5:35 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 5:59 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Darden Restaurants (DRI) Set to Serve Up an 8% Move After Q1 Earnings, Say Options Traders — source image
Decision brief

The 30-second read

$DRINeutralLow
01

Why it matters

The upcoming earnings report is the primary catalyst; options pricing suggests traders anticipate a sizable move.

02

Market read

Earnings preview with implied volatility may drive short‑term trading activity in DRI.

03

What to watch

Potential impact of the Olive Garden‑Uber delivery partnership on same‑store sales.

Relevance 4/10Novelty 2/10Timing: pre‑earnings week, Sep 24 release

Background

Darden Restaurants is a leading restaurant operator with brands like Olive Garden and LongHorn Steakhouse.

Company-level read

Ticker impact

$DRINeutralMedium confidence
Context

Options market predicts an ~8% move in DRI ahead of its Q1 earnings release on Sep 24.

Expected impact

Expect intraday swing of up to ±8% around the earnings announcement.

Evidence & confidence

Historical post‑earnings moves have been modest; the options market pricing reflects uncertainty rather than a clear directional bias.

Market effects

Restaurant sector may see modest movement as peers react to DRI earnings.

U.S. consumer discretionary sentiment could be slightly affected.

Limited to U.S. markets; no broader macro impact.

Counterpoint

If the options market overestimates volatility, a calm earnings beat could lead to a quick reversal.

Key entities

  • Darden Restaurants

    U.S. restaurant operator (ticker DRI).

  • Uber Technologies

    Partner in Olive Garden delivery service.

Related articles

$CMGMed

Baird Reshuffles Restaurant Ratings: Starbucks, Cava Top Picks as Chipotle, Domino's Cut to Neutral — BigGo Finance

Baird downgraded Chipotle (CMG) to Neutral, cutting its price target to $40, citing slower growth and higher reinvestment needs. Domino's (DPZ) and Black Rock Coffee Bar (BRCB) were also downgraded. Darden (DRI) was upgraded to Outperform with a $250 target. Baird favors Cava (CAVA), Starbucks (SBUX), and others with strong unit economics and growth potential.

$CMGMed

Baird downgrades Chipotle, Domino’s as restaurant divergence widens

Baird downgraded Chipotle (CMG), Domino's (DPZ), and Black Rock Coffee Bar (BRCB) to Neutral, citing slower growth and competitive pressures. It upgraded Darden (DRI) to Outperform, praising its strong fundamentals. Price targets were adjusted for each. Baird also initiated coverage of Brinker (EAT) and Jersey Mike's with Outperform ratings, and named Cava (CAVA), Brinker, Starbucks (SBUX), and Dutch Bros (BROS) as top picks.

$DRIHighAI 8/10

Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?

Darden Restaurants (DRI) reached a 52-week high in 2026, with fiscal sales surpassing $13 billion. Key brands like Olive Garden and LongHorn Steakhouse drove growth, with Q4 revenue up 13.7% YoY. Darden's stock rose 18% this year, supported by strong earnings and a new $1.5 billion share repurchase plan. The company provided optimistic 2027 guidance, including sales between $13.6B and $13.75B. Competitors like Domino's (DPZ) and Chipotle (CMG) faced weaker sales and stock declines.

$DRIMed

DRI Healthcare Announces Receipt of Put Price on EKTERLY

DRI Healthcare Trust (TSX: DHT.UN, DHT.U) said it received about US$178 million as the put price after exercising a contractual put option tied to its royalty participation right in EKTERLY. The put was exercised after Chiesi Group completed its acquisition of KalVista Pharmaceuticals. The transaction is now complete and the royalty right has terminated.